Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cleveland, TN
NPI
1861612103
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
2350 N Ocoee St
Cleveland, TN, 37311
Phone (423) 244-9262
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
1,097 services
Medicare patients, 2024
259
Average age 73
Drug cost, 2024
$1.0M
2,441 prescriptions
Company payments, 2025
$1,437
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Prashanth Chandra Sekhar was code 99214 (office e&m - established), 302 times for 174 patients. In total Prashanth Chandra Sekhar billed 1,097 services in 15 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 302 | 174 | $82.29 | $25K |
| 36415 Venipuncture Blood Collection | Office | 247 | 169 | $8.36 | $2,064 |
| 83036 Blood Count | Office | 148 | 85 | $9.23 | $1,366 |
| 82962 Clinical Chemistry | Office | 132 | 77 | $3.14 | $414 |
| 95251 Test - Miscellaneous | Office | 93 | 47 | $23.78 | $2,211 |
| 99205 Office E&M - New | Office | 53 | 53 | $140.39 | $7,441 |
| 99204 Office E&M - New | Office | 52 | 52 | $111.49 | $5,798 |
| 99213 Office E&M - Established | Office | 30 | 29 | $64.23 | $1,927 |
| 82044 Clinical Chemistry | Office | 27 | 27 | $5.92 | $160 |
By year: 2022 $32K for 655 services; 2023 $53K for 1,186 services; 2024 $47K for 1,097 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 247 | 169 | $8.36 | $2,064 |
| 83036 Blood Count | 148 | 85 | $9.23 | $1,366 |
| 82962 Clinical Chemistry | 132 | 77 | $3.14 | $414 |
| 82044 Clinical Chemistry | 27 | 27 | $5.92 | $160 |
Medicare prescription drug claims, 2024
In 2024, the drug Prashanth Chandra Sekhar prescribed most often to Medicare patients was Levothyroxine Sodium, with 222 prescriptions and refills. In total Prashanth Chandra Sekhar wrote 2,441 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 222 | 392 | 49 | $1,421 |
| Methimazole Generic | 160 | 298 | 37 | $1,931 |
| Tresiba Flextouch U-100 Insulin Degludec | 135 | 283 | 45 | $81K |
| Ozempic Semaglutide | 120 | 169 | 27 | $151K |
| Jardiance Empagliflozin | 118 | 185 | 31 | $104K |
| Novolog Flexpen Insulin Aspart | 100 | 200 | 41 | $29K |
| Mounjaro Tirzepatide | 99 | 113 | 14 | $116K |
| Metformin Hcl Generic | 74 | 196 | 25 | $413 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 71 | 174 | 25 | $68K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 64 | 177 | 31 | $8,250 |
| Synthroid Levothyroxine Sodium | 64 | 131 | 20 | $4,978 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 62 | 171 | 26 | $8,023 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 58 | 141 | 18 | $8,161 |
| Humalog Kwikpen U-100 Insulin Lispro | 54 | 99 | 16 | $18K |
| Atorvastatin Calcium Generic | 52 | 130 | 18 | $820 |
Brand drugs: 1,459 claims; generic drugs: 740 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Prashanth Chandra Sekhar $1,437 ($1,437 in general payments such as food, travel and fees) from 25 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $230.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 5 | $230 |
| Insulet Corporation PODD | 5 | $114 |
| Dexcom, Inc. DXCM | 4 | $103 |
| Janssen Biotech, Inc. JNJ | 4 | $94.52 |
| Amgen Inc. AMGN | 5 | $93 |
| Sequel Med Tech, LLC | 3 | $87.86 |
| Radius Health, Inc. | 3 | $85.13 |
| Mallinckrodt Hospital Products Inc. | 3 | $80.02 |
| CeQur Corporation | 1 | $69.68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.